Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.
企業コードEMBC
会社名Embecta Corp
上場日Mar 21, 2022
最高経営責任者「CEO」Kurdikar (Devdatt)
従業員数1850
証券種類Ordinary Share
決算期末Mar 21
本社所在地300 Kimball Drive
都市PARSIPPANY
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号07054
電話番号18624010000
ウェブサイトhttps://www.embecta.com/
企業コードEMBC
上場日Mar 21, 2022
最高経営責任者「CEO」Kurdikar (Devdatt)